Butler John P.

Butler John P. is listed in filings as CEO and President at Akebia Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 5, 2026, including purchase activity and sale activity. Recent filings connect the profile to Akebia Therapeutics, Inc. (AKBA). The current snapshot covers public activity from Feb 4, 2025 to Mar 5, 2026. Reported amounts are shown as $86.6K to $159.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.